Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Primary Care Sales Force Downsizing Will Continue, Bristol Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Bristol-Myers Squibb expects additional downsizing of its primary care sales force as it shifts its product portfolio to specialty care, Exec VP Donald Hayden told analysts July 29
Advertisement

Related Content

Bristol Continues To Refocus Marketing By Outsourcing Cefzil And Tequin
Bristol Continues To Refocus Marketing By Outsourcing Cefzil And Tequin
Bristol To Devote $125 Mil. To Develop Medarex' Metastatic Melanoma Agent
Bristol To Devote $125 Mil. To Develop Medarex' Metastatic Melanoma Agent
Bristol Will Use Partners To Maintain Primary Care Presence
Bristol Will Use Partners To Maintain Primary Care Presence
Sanofi, Bristol Discussing Changes To Avapro Agreement
Primary Care Rx Market Offers Second-Rate Return On Investment, Bristol Says
Primary Care Rx Market Offers Second-Rate Return On Investment, Bristol Says
Merck Gets Second Chance On Dual PPAR: Will Co-Develop Bristol's Muraglitazar

Topics

Advertisement
UsernamePublicRestriction

Register

PS060177

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel